Phio stockholders approve 950,000-share increase to 2020 LTIP plan; adopt 3-year say-on-pay frequency

Phio Pharmaceuticals Corp.

All six director nominees elected with 84-94% of votes cast; 1,828,465 broker non-votes.
Grant Thornton ratified as auditor for FY2025 with 2,330,465 votes for, 40,532 against.
2020 Plan amendment approved with 387,895 for, 152,069 against; shares available increased to 1,023,017.
Non-binding say-on-pay passed with 474,987 for (87% of votes cast).
Stockholders preferred 3-year say-on-pay frequency (276,177 votes); board adopted triennial vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.